Imexpharm Corp (IMP) — Cash Flow Quality Index
Imexpharm Corp (IMP) has a Cash Flow Quality Index of 1.26x as of March 2026. Operating cash flow of ₫103.49 Billion exceeds net income of ₫82.02 Billion, indicating high earnings quality where cash backs reported profits. Explore IMP operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Imexpharm Corp Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Imexpharm Corp across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check IMP total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Imexpharm Corp (2019–2025)
Year-by-year earnings quality comparison for Imexpharm Corp. For live market cap and the full company financial profile, see Imexpharm Corp stock valuation.
| Year | Quality Index | Operating CF (VND) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | ₫54.17 Billion | ₫349.14 Billion | ▼ -77.0% |
| 2024 | 0.67x | ₫216.27 Billion | ₫320.86 Billion | ▲ +598.9% |
| 2023 | -0.14x | ₫-40.47 Billion | ₫299.56 Billion | ▼ -108.3% |
| 2022 | 1.62x | ₫378.60 Billion | ₫233.96 Billion | ▲ +30.3% |
| 2021 | 1.24x | ₫234.88 Billion | ₫189.09 Billion | ▲ +256.1% |
| 2020 | 0.35x | ₫73.15 Billion | ₫209.70 Billion | ▼ -14.9% |
| 2019 | 0.41x | ₫66.59 Billion | ₫162.39 Billion | — |